Hamid, SS, et al.
Fulminant hepatic failure in pregnant women: acute fatty liver or acute viral hepatitis?
Journal of Hepatology
1996; 25: 20–27.
Banait, VS, et al.
Outcome of acute liver failure due to acute hepatitis E in pregnant women. Indian Journal of Gastroenterology
2007; 26: 6–10.
Khuroo, MS. Hepatitis E: an emerging global disease – from discovery towards control and cure. Journal of Viral Hepatitis
2016; 23: 68–79.
Mirazo, S, et al.
Transmission, diagnosis, and management of hepatitis E: an update. Hepatic Medicine: Evidence and Research
2014; 6: 45–59.
Rein, DB, et al.
The global burden of hepatitis E virus genotypes 1 and 2 in 2005. Hepatology
2012; 55: 988–997.
Conteh, L, Engels, T, Molyneux, DH. Socioeconomic aspects of neglected tropical diseases. Lancet
2010; 375: 239–247.
Wu, T, et al.
Hepatitis E vaccine development A 14-year odyssey. Human Vaccines & Immunotherapeutics
2012; 8: 823–827.
Xiu, SX. Disease burden of hepatitis E and health economic evaluation of vaccine interventions in Dongtai Area. Southeast University, 2011.
Jiang, M, et al.
Economic burden of patients with hepatitis E and influencing factors in Yantai city, China. Chinese Journal of Epidemiology
2011; 32: 845–846.
Zhu, FC, et al.
Efficacy and safety of a recombinant hepatitis E vaccine in healthy adults: a large-scale, randomised, double-blind placebo-controlled, phase 3 trial. Lancet
2010; 376: 895–902.
Zhu, FC, et al.
Epidemiology of zoonotic hepatitis E: a community-based surveillance study in a rural population in China. PLoS ONE
2014; 9: e87154.
Xie, Z, et al.
Posthospital discharge medical care costs and family burden associated with osteoporotic fracture patients in China from 2011 to 2013. Journal of Osteoporosis
2015; 25: 1–6.
Tarricone, R. Cost-of-illness analysis. What room in health economics?
2006; 77: 51–63.
Ogwulu, CB, et al.
Exploring the intangible economic costs of stillbirth. BMC Pregnancy and Childbirth
2015; 15: 188.
Wundes, A, et al.
Contribution of intangible costs to the economic burden of multiple sclerosis. Journal of Medical Economics
2010; 13: 626–632.
The EuroQol Group. EQ-5D-3L user guide: basic information on how to use the EQ-5D-3L instrument, 2015.
Tsuchiya, A, et al.
Estimating an EQ-5D population value set: the case of Japan. Health economics
2002; 11: 341–353.
Zhang, M, et al.
Analysis on morbidity and mortality of viral hepatitis in China, 2004–2013. Chinese Journal of Epidemiology
2015; 36: 144–147.
Anon. Hepatitis E vaccine: WHO position paper, May 2015. Weekly Epidemiological Record
2015; 90: 185–200.
Zhang, J, et al.
Long-term efficacy of a hepatitis E vaccine. New England Journal of Medicine
2015; 372: 914–922.
Pan, J, et al.
Benefit distribution of social health insurance: evidence from China's urban resident basic medical insurance. Health Policy and Planning
Meng, Q, et al.
Consolidating the social health insurance schemes in China: towards an equitable and efficient health system. Lancet
2015; 386: 1484–1492.
Mahmood, MA, et al.
Cooperative medical insurance and the cost of care in Shandong, PR China: perspectives of patients and community members. Asia-Pacific Journal of Public Health
2015; 27: 897–902.
Kamar, N, et al.
Hepatitis E. Lancet
2012; 379: 2477–2488.
Jia, Z, et al.
Epidemiology of hepatitis E virus in China: results from the Third National Viral Hepatitis Prevalence Survey, 2005–2006. PLoS ONE
2014; 9: e110837.
Jin, H, et al.
Comparison between EQ-5D and SF-6D utility in rural residents of Jiangsu Province, China. PLoS ONE
2012; 7: e41550.
Jia, YX, et al.
Comparison between the EQ-5D-5L and the EQ-5D-3L in patients with hepatitis B. Quality of Life Research
2014; 23: 2355–2363.
Steinke, DT, et al.
Epidemiology and economic burden of viral hepatitis: an observational population based study. Gut
2002; 50: 100–105.
Shon, C, et al.
The economic burden of hepatitis A, B, and C in South Korea. Japanese Journal of Infectious Diseases
2016; 69: 18–27.